We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
23 hedge funds and large institutions have $109M invested in Enzymotec Ltd in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
4,535% more capital invested
Capital invested by funds: $2.35M → $109M (+$107M)
2,100% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 1
1,050% more funds holding
Funds holding: 2 → 23 (+21)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
23
Holders Change
+21
Holders Change %
+1,050%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PC
Paulson & Co
New York
|
+$41.2M |
| 2 |
VAM
Visium Asset Management
New York
|
+$16.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.3M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$5.19M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$4.97M |
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$828K |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$188K |
